Trastuzumab Cardiotoxiciy: The Age-Old Balance of Risk and Benefit

British Journal of Cancer - United Kingdom
doi 10.1038/bjc.2016.381
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Springer Science and Business Media LLC

Related search

Federal Old-Age Insurance: Benefit Payments and Tax Collection

Law and Contemporary Problems
Law
1936English

The Risk-Benefit Balance in the United States: Who Decides?

Health Affairs
MedicineHealth Policy
2007English

Early Immune Modulation by Single-Agent Trastuzumab as a Marker of Trastuzumab Benefit

British Journal of Cancer
Cancer ResearchOncology
2018English

Vulnerability and Social Exclusion: Risk in Adolescence and Old Age

2019English

Removing the Age Restrictions for Rotavirus Vaccination: A Benefit-Risk Modeling Analysis

PLoS Medicine
BiochemistryBiotechnologyMolecular BiologyCell BiologyMedicine
2012English

The Assessment of Potential Benefit and Risk Balance in the Process of Clinical Practice Guidelines Development and Grading the Evidence

Medical Technologies. Assessment and Choice (Медицинские технологии. Оценка и выбор)
2019English

When Can Insurers Offer Products That Dominate Delayed Old-Age Pension Benefit Claiming?

SSRN Electronic Journal
2010English

Risk and Benefit

Nature
Multidisciplinary
1998English

Lifetime Income and Old Age Mortality Risk in Italy Over Two Decades

Demographic Research
Demography
2013English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2025 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy